Preliminary study about the possible glycemic clinical advantage in using a fixed combination of Berberis aristata and Silybum marianum standardized extracts versus only Berberis aristata in patients with type 2 diabetes

Francesco Di Pierro, Nicola Villanova, Pietro Putignano et al.|Clinical Pharmacology Advances and Applications|2013

Cited by 78